Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02728531 |
|---|---|
| Brief Title: | Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma |
| First Submitted : | March 30, 2016 |
| First Submitted that Met QC Criteria : | March 30, 2016 |
| First Posted : | April 5, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 18, 2020 |
| Last Update Posted : | May 19, 2020 |